BlackRock Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $367K | Buy |
4,627
+117
| +3% | +$9.28K | ﹤0.01% | 2339 |
|
|
2016
Q3 | $316K | Sell |
4,510
-5,555
| -55% | -$389K | ﹤0.01% | 2359 |
|
|
2016
Q2 | $390K | Sell |
10,065
-6,635
| -40% | -$257K | ﹤0.01% | 2212 |
|
|
2016
Q1 | $676K | Buy |
16,700
+291
| +2% | +$11.8K | ﹤0.01% | 1901 |
|
|
2015
Q4 | $1.46M | Sell |
16,409
-12,377
| -43% | -$1.1M | ﹤0.01% | 1521 |
|
|
2015
Q3 | $2.13M | Sell |
28,786
-1,482
| -5% | -$110K | ﹤0.01% | 1320 |
|
|
2015
Q2 | $2.45M | Buy |
+30,268
| New | +$2.45M | ﹤0.01% | 1156 |
|
|
2014
Q3 | – | Sell |
-1,570
| Closed | -$22K | – | 3658 |
|
|
2014
Q2 | $22K | Buy |
1,570
+208
| +15% | +$2.92K | ﹤0.01% | 3393 |
|
|
2014
Q1 | $17K | Buy |
+1,362
| New | +$17K | ﹤0.01% | 3423 |
|